SK Capital sells IBA Molecular to CapVest
SK Capital (SK), a private investment firm focused on the specialty materials, chemicals and healthcare sectors, is to sell IBA Molecular (IBAM) to funds advised by CapVest Partners LP (CapVest). The transaction is expected to close at the end of Q1 2016. IBA Molecular is a leading developer, manufacturer and
